Paper Details

  1. Home
  2. Paper Details

Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias.

Author: ClarkP I, GlasserS P, LadduA R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Propranolol and acebutolol significantly reduced premature ventricular contractions (PVCs) compared to placebo in 21 patients. Acebutolol was safe and effective, comparable to propranolol, with mild and infrequent side effects.
Paper Details　
Original Abstract of the Article :
This study was designed to assess the relative antiarrhythmic activity of fixed doses of 2 beta-adrenergic blocking agents, propranolol and acebutolol, in a prospective double-blind crossover trial. Twenty-one patients who had at least 30 premature ventricular contractions (PVCs) per hour while rece...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0002-9149(83)90518-0

データ提供：米国国立医学図書館（NLM）

Acebutolol vs. Propranolol: A Race to the Finish Line

The world of heart rhythm disorders is a complex and fascinating one, my friends. It's like a desert race, where each beat of the heart is a step towards the finish line. This study compares the antiarrhythmic effects of two beta-blockers, acebutolol and propranolol, in patients experiencing ventricular arrhythmias. The researchers conducted a prospective, double-blind crossover trial involving 21 patients with frequent premature ventricular contractions (PVCs). The study was like a caravan of camels, each carrying a different beta-blocker, racing to see which could best control the arrhythmias.

Acebutolol: A Worthy Competitor in the Race

The researchers found that both acebutolol and propranolol effectively reduced the number of PVCs compared to placebo. While the study didn't show a significant difference between the two beta-blockers, acebutolol emerged as a safe and effective treatment option for ventricular arrhythmias. It's like a camel that can withstand the harsh conditions of the desert, providing a reliable and effective solution.

Choosing the Right Path for Heart Health

This study sheds light on the potential benefits of both acebutolol and propranolol in managing ventricular arrhythmias. While further research is needed to fully understand the nuances of their effects, this study suggests that both beta-blockers can be valuable tools in the fight against heart rhythm disorders. It's like a well-traveled desert path, offering different routes to reach the desired destination of heart health.

Dr.Camel's Conclusion

This study demonstrates the efficacy of both acebutolol and propranolol in controlling ventricular arrhythmias. By understanding the comparative effects of these beta-blockers, healthcare professionals can make informed decisions to optimize the care of patients experiencing heart rhythm disorders. It's a reminder that the journey towards heart health is not a single path but a multitude of options, each with its own strengths and weaknesses.

Date :
  1. Date Completed 1983-12-17
  2. Date Revised 2019-06-22
Further Info :

Pubmed ID

6195911

DOI: Digital Object Identifier

10.1016/0002-9149(83)90518-0

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.